Brief: Design Therapeutics Posts Quarterly Loss Per Share Of $0.14
09/08/2021 21:48
Aug 9 (Reuters) - Design Therapeutics Inc DSGN.O :
* DESIGN THERAPEUTICS REPORTS GENETAC™ PORTFOLIO PROGRESS
AND
SECOND QUARTER 2021 RESULTS
* DESIGN THERAPEUTICS INC- QTRLY LOSS PER SHARE $0.14
Source text for Eikon: ID:nGNXc3VGQS
Further company coverage: DSGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Design Therapeutics
See all newsDesign Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Design Therapeutics Q2 net loss narrower than expected
Brief: Design Therapeutics Q2 Basic EPS USD -0.32
Design Therapeutics Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: Design Therapeutics Announces Initiation Of Patient Dosing In Phase 1 Multiple Ascending Dose Trial Of Dt-818 For Myotonic Dystrophy Type-1